Fatigue is a common side effect of cancer and cancer treatment. This updated page explains the causes of cancer fatigue and what you can do to manage it.
In a clinical trial, people being treated for cancer who took part in mind–body fitness classes live over Zoom were less likely to be admitted to the hospital and had shorter stays when they were in the hospital than people who did not take the classes.
NCI’s James H. Doroshow, M.D., reflects on NCI-MATCH, a first-of-its-kind precision medicine cancer trial. He also gives an overview of the three new trials to come out of NCI-MATCH: ComboMATCH, MyeloMATCH, and iMATCH.
Antibodies used in many cancer treatments have only been able to reach proteins outside of cancer cells. In a new study in mice, scientists found a way to target cancer-fueling KRAS and IDH1 proteins buried inside cancer cells.
The Food and Drug Administration has approved toripalimab-tpzi (Loqtorzi) to be used alone or with other drugs to treat nasopharyngeal cancer. It is used in certain adults whose cancer has spread, come back, and cannot be removed with surgery.
